MW-11
N/A
Report date: 2026/04/05 20:00:15
Base Information
Drug NameMW-11
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMabwell (Shanghai) Bioscience Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesJiangsu T-Mab Bio-Pharmaceuticals Co LtdJiangsu Haibo Biopharmaceutical Co LtdJiangsu Maiweikang New Drug R & D Co Ltd +[5]
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A